Medlab Clinical: A new focus on patient suffering

Medlab Clinical: A new focus on patient suffering

Even in today’s world of exponential technology and wonder drugs, patients all over the world still have extreme, desperate experiences.

Constant pain and uncontrollable distress remain the inevitable consequences of medical conditions and even some clinician-prescribed treatments. Founded in response to personal experience, ASX-listed biotechnology company Medlab Clinical has a mission to help to reduce even the most extreme moments of suffering, making them calmer and easier to bear. 

In this film, we catch up with Medlab’s CEO Sean Hall to find out how its focus on improving the patient’s ‘now’ is defining its business.

Want to receive content on Medlab Clinical? Complete the form below.

An unfinished ecosystem: The ever-changing face of investor relations

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free